Cantitate/Preț
Produs

Fatty Liver Disease

Editat de Geoffrey C Farrell, Jacob George, Pauline de La M Hall, Arthur J McCullough
en Limba Engleză Hardback – 10 dec 2004
Fatty liver disease, especially non-alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease - affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents (particularly Asia, South America and South Africa).
NASH is the form of fatty liver disorder which can result in cirrhosis, particularly in those with diabetes or who are overweight, yet it is still not widely recognised despite its already high and increasing prevalence worldwide. This book explains what NASH is, why it happens, who gets it, how it can result in cirrhosis, when to think about it, how to select practical management between those with a minor abnormality from those who may have cirrhosis, and how to prevent and treat this ubiquitous condition.

Fatty Liver Diseases: NASH and Related Disorders is an unusual book: it combines a practical approach for students and physicians concerned with the problem with a clear overview on the causative mechanisms. It should appeal to doctors and other health care workers who encounter this problem, as well as to pathologists and investigators interested in the field of liver disease.
Citește tot Restrânge

Preț: 132001 lei

Preț vechi: 138949 lei
-5%

Puncte Express: 1980

Preț estimativ în valută:
23344 27394$ 20247£

Carte tipărită la comandă

Livrare economică 10-24 martie


Specificații

ISBN-13: 9781405112925
ISBN-10: 1405112921
Pagini: 336
Dimensiuni: 183 x 260 x 23 mm
Greutate: 0.98 kg
Ediția:New.
Editura: Wiley
Locul publicării:Chichester, United Kingdom

Public țintă

Discipline: Gastroenterology & Hepatology
Primary market: Gastroenterologists, Hepatologists

Secondary market: Diabetologists, Specialists in Obesity & metabolism, nutritionists, pathologists,

Descriere

Fatty liver disease, especially non--alcoholic steatohepatitis (NASH), is emerging as the most common form of liver disease -- affecting at least 5% of the population of western countries with increasing incidence in developing economies in other continents (particularly Asia, South America and South Africa).